Von Willebrand factor collagen binding activity in diagnosis of von Willebrand disease: an alternative to ristocetin cofactor activity?
Recombinant human
von Willebrand factor (rhVWF): first-in-human study evaluating pharmacokinetics, demonstrating safety and tolerability in type 3 von Willebrand disease.
This means that all of the reagents necessary to test for the presence of
von Willebrand Factor are available from Bio/Data," said Eugene J.
Human coagulation factor VIII and
von Willebrand factor VIII and 190 iu 250U
von Willebrand factordoes not contain
von Willebrand factor, and, therefore, is not indicated in von Willebrand's disease.
Contract award: the concentrate of human coagulation factor viii containing
von willebrand factor in the treatment of von willebrand disease.
VWD is caused by a lack of working
von Willebrand factor (VWF), a protein in the blood that is necessary for clotting.
Occlusin(TM) Injection is a novel product consisting of deformable particles that, through the action of
von Willebrand factor (VWF) bound to the particle fibres, capture and activate platelets at the site of delivery leading to localized clot formation.
Food and Drug Administration today approved Vonvendi,
von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD).
Mannucci, from the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center of Milan (Italy), the treatment of severe hemophilia A with recombinant factor VIII (rFVIII) is associated with an 87% higher incidence of inhibitors than treatment with plasma-derived factor VIII containing
von Willebrand factor (pdFVIII/VWF).
An EIA for the quantification of human
von Willebrand factor antigen in plasma.
Von Willebrand Factor (VWF) is a polymeric plasma glycoprotein comprising multiple 250-kDa subunits that facilitates platelet adhesion to the vessel wall by linking platelet membrane receptors to the subendothelium and is the cornerstone of platelet--endothelial interaction.